ZR2 BIOENERGY LIMITED

ZR2 Bioenergy Limited, formerly Gujchem Distillers India Limited, has strategically pivoted its business towards bioenergy and green hydrogen. The company aims to operate a cane-based biorefinery and an integrated biogas plant, producing ethanol, Compressed Biogas (CBG), green hydrogen, bio-potash, and exportable power. Its primary customers include Oil Marketing Companies (OMCs) and government agencies, with operations initially focused in Maharashtra, India. The company also plans to collaborate with local farmers for feedstock procurement.

Key facts (FY 2024-25)

• Promoter: ZR2 Group Holdings Limited holds a 60.96% stake in the company.
• Name Change: The company officially changed its name from Gujchem Distillers India Limited to ZR2 Bioenergy Limited on March 27, 2025, to align with its new business focus.
• Subsidiary: Incorporated ZR2 Solar Private Limited as a wholly-owned subsidiary on October 4, 2024.
• Assets Acquired: Acquired a fully operational distillery/ethanol/ENA/raw biogas/MEE/RO plant and two land parcels (82.75 acres and 24.48 acres) for expansion.
• Standalone Revenue: ₹149.45 Lakhs.
• Standalone Profit After Tax: ₹8.22 Lakhs.

Recent developments (FY 2024-25)

• Strategic re-alignment towards bioenergy and green hydrogen, driven by a new management takeover.
• Raised ₹248.77 Crores through a Preferential Issue of Compulsory Convertible Debentures and Warrants, fully subscribed by promoters and public investors, incurring no external debt in the acquisition phase.
• Planned phased expansion (Phase II by FY 2025-26, Phase III by FY 2026-27) includes expanding ethanol capacity, upgrading biogas plants, implementing Zero Liquid Discharge (ZLD), recovering biopotash, and developing solar and green hydrogen facilities.
• Approved shifting its registered office from Gujarat to Maharashtra to enhance access to banks, investors, and improve administrative efficiency.
• Expects to commence manufacturing activities by the end of FY 2024-25, pending the formal execution of a Build-Own-Operate-Transfer (BOOT) Agreement and additional approvals.

Key risks flagged by management

• Feedstock price volatility: Mitigated by diversified sourcing (cane + grain) and long-term procurement agreements.
• Policy risk: Ethanol prices are linked to administered pricing mechanisms, but this is offset by integrated bio-refinery operations.
• Environmental constraints: Requires continuous focus on ZLD compliance, water usage, and overall sustainability practices.
• Operational delays: Commencement of production is contingent on finalization of legal documentation for the BOOT agreement and other regulatory approvals.

Pros

• Strategic pivot into high-growth bioenergy and green hydrogen sectors, aligned with national energy transition goals.
• Strong financial flexibility demonstrated by debt-free acquisition and substantial equity infusion (₹12,239.83 Lakhs from equity instruments).
• Integrated bioenergy strategy diversifying future revenue streams from ethanol, CBG, hydrogen, bio-potash, and power exports, supported by assured feedstock and off-take commitments.

Cons

• Core bioenergy manufacturing operations are yet to commence as of March 31, 2025, due to pending formal agreements and approvals.
• Standalone Profit After Tax significantly declined from ₹38.92 Lakhs in FY 2023-24 to ₹8.22 Lakhs in FY 2024-25.
• A substantial portion of investment is held as Capital Work-in-Progress (₹11,889.68 Lakhs Standalone) indicating large non-operational assets and associated execution risks.